ASX:RAP

ResApp Health Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume932,978 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

ResApp Health (ASX:RAP) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying RAP stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to ResApp Health, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

1st Group (ASX:1ST) and ResApp Health (ASX:RAP) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

Profitability

This table compares 1st Group and ResApp Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
ResApp HealthN/AN/AN/A

Valuation & Earnings

This table compares 1st Group and ResApp Health's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
ResApp Health$46,197.000.00$-8,408,059.26A($0.01)N/A

1st Group has higher revenue and earnings than ResApp Health.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for 1st Group and ResApp Health, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
ResApp Health0000N/A

Summary

1st Group beats ResApp Health on 3 of the 3 factors compared between the two stocks.

Alcidion Group (ASX:ALC) and ResApp Health (ASX:RAP) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Earnings and Valuation

This table compares Alcidion Group and ResApp Health's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A
ResApp Health$46,197.000.00$-8,408,059.26A($0.01)N/A

Alcidion Group has higher revenue and earnings than ResApp Health.

Profitability

This table compares Alcidion Group and ResApp Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Alcidion GroupN/AN/AN/A
ResApp HealthN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and price targets for Alcidion Group and ResApp Health, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Alcidion Group0000N/A
ResApp Health0000N/A

Summary

Alcidion Group beats ResApp Health on 3 of the 3 factors compared between the two stocks.

ResApp Health (ASX:RAP) and Binovi Technologies (OTCMKTS:BNVIF) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.

Valuation & Earnings

This table compares ResApp Health and Binovi Technologies' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ResApp Health$46,197.000.00$-8,408,059.26A($0.01)N/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Binovi Technologies has lower revenue, but higher earnings than ResApp Health.

Profitability

This table compares ResApp Health and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ResApp HealthN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for ResApp Health and Binovi Technologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ResApp Health0000N/A
Binovi Technologies0000N/A

Summary

ResApp Health beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Cann American (CNSX:CNNA) and ResApp Health (ASX:RAP) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

Profitability

This table compares Cann American and ResApp Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cann AmericanN/AN/AN/A
ResApp HealthN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations for Cann American and ResApp Health, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cann American0000N/A
ResApp Health0000N/A

Valuation and Earnings

This table compares Cann American and ResApp Health's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cann AmericanN/AN/AN/AN/AN/A
ResApp Health$46,197.000.00$-8,408,059.26A($0.01)N/A

Cann American has higher earnings, but lower revenue than ResApp Health.

Summary

ResApp Health beats Cann American on 1 of the 1 factors compared between the two stocks.

CannaOne Technologies (OTCMKTS:CNONF) and ResApp Health (ASX:RAP) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Analyst Recommendations

This is a summary of current ratings and recommmendations for CannaOne Technologies and ResApp Health, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CannaOne Technologies0000N/A
ResApp Health0000N/A

Earnings and Valuation

This table compares CannaOne Technologies and ResApp Health's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CannaOne TechnologiesN/AN/AN/AN/AN/A
ResApp Health$46,197.000.00$-8,408,059.26A($0.01)N/A

CannaOne Technologies has higher earnings, but lower revenue than ResApp Health.

Profitability

This table compares CannaOne Technologies and ResApp Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CannaOne TechnologiesN/AN/AN/A
ResApp HealthN/AN/AN/A

Summary

ResApp Health beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and ResApp Health (ASX:RAP) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Analyst Ratings

This is a summary of current ratings and target prices for CloudMD Software & Services and ResApp Health, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services00203.00
ResApp Health0000N/A

CloudMD Software & Services presently has a consensus price target of $3.3750, indicating a potential upside of 122.04%.

Profitability

This table compares CloudMD Software & Services and ResApp Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
ResApp HealthN/AN/AN/A

Valuation and Earnings

This table compares CloudMD Software & Services and ResApp Health's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesN/AN/AN/AN/AN/A
ResApp Health$46,197.000.00$-8,408,059.26A($0.01)N/A

CloudMD Software & Services has higher earnings, but lower revenue than ResApp Health.


ResApp Health Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.05flat$0.00N/A0.00Gap Up
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$1.04flat$0.00N/A0.00Gap Down
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.56flat$0.00N/A0.00
DOC
CloudMD Software & Services
1.2$1.96flatC$0.00C$11.65 million-21.78
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11flat$0.00N/A0.00Gap Up
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00
FORA
Forian
0.3$11.83flat$0.00N/A0.00
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$76.00flat$0.00N/A0.00
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
News Coverage
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.38flat$0.00N/A0.00Gap Down
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.06flat$0.00N/A0.00
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.85flat$0.00N/A0.00
CBIIF
Skylight Health Group
0.0$0.96flat$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.10flat$0.00N/A0.00Gap Up
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$5.66flat$0.00N/A0.00News Coverage
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.